Please enable JavaScript to continue using this application.

Compare $CUE vs $IVVD | Chartloom

Compare

$CUE vs $IVVD

Cue Biopharma Inc · Invivyd Inc

CUE

Cue Biopharma Inc

IVVD

Invivyd Inc

Compare $CUE vs $IVVD

Comparing Cue Biopharma Inc and Invivyd Inc

CUECue Biopharma Inc

IVVDInvivyd Inc

CUECue Biopharma Inc

Market cap

$112M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

354.4%

YTD performance

173.6%

52W performance

7.5%

FCF yield

-44.8%

IVVDInvivyd Inc

Market cap

$212M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.13x

Rev growth (TTM)

26.3%

YTD performance

-71.2%

52W performance

-56.0%

FCF yield

-51.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CUE

IVVD

Detailed metrics comparison

CUE

Cue Biopharma Inc

IVVD

Invivyd Inc

Market Cap

CUE$112M

IVVD$212M

Enterprise Value

CUE$95M

IVVD$52M

Price

CUE$27.66

IVVD$0.72

P/E Ratio

CUEN/A

IVVDN/A

P/S Ratio

CUE2.98x

IVVD3.64x

EV/Sales

CUE2.51x

IVVD0.90x

EV/EBITDA

CUE0.00x

IVVD0.00x

P/B Ratio

CUE80.41x

IVVD1.34x

P/FCF Ratio

CUEN/A

IVVDN/A

EV/FCF

CUE-1.89x

IVVD-0.48x

PEG Ratio

CUEN/A

IVVDN/A

Forward P/E (NTM)

CUEN/A

IVVDN/A

Forward P/S (NTM)

CUEN/A

IVVD3.13x

Revenue (TTM)

CUE$38M

IVVD$58M

Revenue Growth (YoY)

CUE354.4%

IVVD26.3%

Forward Rev Growth

CUE-38.2%

IVVD44.8%

Gross Margin (TTM)

CUE0.0%

IVVD92.2%

Operating Margin (TTM)

CUE0.0%

IVVD0.0%

EBITDA Margin (TTM)

CUE-258.4%

IVVD-191.7%

Net Margin (TTM)

CUE-435.8%

IVVD-183.9%

FCF Margin (TTM)

CUE-133.2%

IVVD-187.9%

Net Income (TTM)

CUE$-164M

IVVD$-107M

FCF (TTM)

CUE$-50M

IVVD$-110M

EPS (TTM)

CUE-$25.88

IVVD-$0.33

ROE (TTM)

CUE-103219.0%

IVVD-5973.0%

ROA (TTM)

CUE-48467.0%

IVVD-4897.0%

ROIC (TTM)

CUE-100612.0%

IVVD-5973.0%

Cash

CUE$17M

IVVD$160M

Debt

CUE$0

IVVD$0

Net Cash/Debt

CUE$17M

IVVD$160M

Current Ratio (TTM)

CUE1.25x

IVVD5.87x

Quick Ratio (TTM)

CUE1.16x

IVVD5.60x

Debt/Equity (TTM)

CUE0.00x

IVVD0.00x

Debt/Assets (TTM)

CUE0.0%

IVVD0.0%

Interest Coverage (TTM)

CUEN/A

IVVDN/A

Net Debt/EBITDA (TTM)

CUE0.00x

IVVD0.00x

Beta

CUE2.84

IVVD1.32

52W Performance

CUE7.5%

IVVD-56.0%

YTD Performance

CUE173.6%

IVVD-71.2%

% from 52W High

CUE-39.2%

IVVD-76.5%

% from 52W Low

CUE456.4%

IVVD36.7%

Asset Turnover (TTM)

CUE1.11x

IVVD0.27x

FCF Yield (TTM)

CUE-44.8%

IVVD-51.6%

Earnings Yield (TTM)

CUE-146.5%

IVVD-50.5%

Dividend Yield (TTM)

CUEN/A

IVVDN/A

Rule of 40

CUE221.1

IVVD-161.6

EV/GP/RG

CUEN/A

IVVD0.06

Ticker research

View CUE research View IVVD research

Metric	CUE Cue Biopharma Inc	IVVD Invivyd Inc
Market & Valuation
Market Cap	$112M	$212M
Enterprise Value	$95M	$52M
Price	$27.66	$0.72
P/E Ratio	N/A	N/A
P/S Ratio	2.98x	3.64x
EV/Sales	2.51x	0.90x
EV/EBITDA	0.00x	0.00x
P/B Ratio	80.41x	1.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.89x	-0.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.13x
Revenue & Growth
Revenue (TTM)	$38M	$58M
Revenue Growth (YoY)	354.4%	26.3%
Forward Rev Growth	-38.2%	44.8%
Profitability
Gross Margin (TTM)	0.0%	92.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-258.4%	-191.7%
Net Margin (TTM)	-435.8%	-183.9%
FCF Margin (TTM)	-133.2%	-187.9%
Net Income (TTM)	$-164M	$-107M
FCF (TTM)	$-50M	$-110M
EPS (TTM)	-$25.88	-$0.33
ROE (TTM)	-103219.0%	-5973.0%
ROA (TTM)	-48467.0%	-4897.0%
ROIC (TTM)	-100612.0%	-5973.0%
Financial Health
Cash	$17M	$160M
Debt	$0	$0
Net Cash/Debt	$17M	$160M
Current Ratio (TTM)	1.25x	5.87x
Quick Ratio (TTM)	1.16x	5.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.84	1.32
52W Performance	7.5%	-56.0%
YTD Performance	173.6%	-71.2%
% from 52W High	-39.2%	-76.5%
% from 52W Low	456.4%	36.7%
Efficiency & Yields
Asset Turnover (TTM)	1.11x	0.27x
FCF Yield (TTM)	-44.8%	-51.6%
Earnings Yield (TTM)	-146.5%	-50.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	221.1	-161.6
EV/GP/RG	N/A	0.06
Ticker research	View CUE research	View IVVD research

Valuation

P/S Ratio

CUE

2.98x

IVVD

3.64x

EV/FCF

CUE

-1.89x

IVVD

-0.48x

Growth & revenue

Revenue Growth TTM

CUE

354.4%

IVVD

26.3%

Forward Revenue Growth

IVVD

44.8%

CUE

-38.2%

Profitability & performance

Gross Margin

IVVD

92.2%

CUE

0.0%

ROE

IVVD

-5973.0%

CUE

-103219.0%

FCF Yield %

CUE

-44.8%

IVVD

-51.6%

52-Week Performance

CUE

7.5%

IVVD

-56.0%

Detailed metrics comparison

CUE

Cue Biopharma Inc

IVVD

Invivyd Inc

Market Cap

CUE$112M

IVVD$212M

Enterprise Value

CUE$95M

IVVD$52M

Price

CUE$27.66

IVVD$0.72

P/E Ratio

CUEN/A

IVVDN/A

P/S Ratio

CUE2.98x

IVVD3.64x

EV/Sales

CUE2.51x

IVVD0.90x

EV/EBITDA

CUE0.00x

IVVD0.00x

P/B Ratio

CUE80.41x

IVVD1.34x

P/FCF Ratio

CUEN/A

IVVDN/A

EV/FCF

CUE-1.89x

IVVD-0.48x

PEG Ratio

CUEN/A

IVVDN/A

Forward P/E (NTM)

CUEN/A

IVVDN/A

Forward P/S (NTM)

CUEN/A

IVVD3.13x

Revenue (TTM)

CUE$38M

IVVD$58M

Revenue Growth (YoY)

CUE354.4%

IVVD26.3%

Forward Rev Growth

CUE-38.2%

IVVD44.8%

Gross Margin (TTM)

CUE0.0%

IVVD92.2%

Operating Margin (TTM)

CUE0.0%

IVVD0.0%

EBITDA Margin (TTM)

CUE-258.4%

IVVD-191.7%

Net Margin (TTM)

CUE-435.8%

IVVD-183.9%

FCF Margin (TTM)

CUE-133.2%

IVVD-187.9%

Net Income (TTM)

CUE$-164M

IVVD$-107M

FCF (TTM)

CUE$-50M

IVVD$-110M

EPS (TTM)

CUE-$25.88

IVVD-$0.33

ROE (TTM)

CUE-103219.0%

IVVD-5973.0%

ROA (TTM)

CUE-48467.0%

IVVD-4897.0%

ROIC (TTM)

CUE-100612.0%

IVVD-5973.0%

Cash

CUE$17M

IVVD$160M

Debt

CUE$0

IVVD$0

Net Cash/Debt

CUE$17M

IVVD$160M

Current Ratio (TTM)

CUE1.25x

IVVD5.87x

Quick Ratio (TTM)

CUE1.16x

IVVD5.60x

Debt/Equity (TTM)

CUE0.00x

IVVD0.00x

Debt/Assets (TTM)

CUE0.0%

IVVD0.0%

Interest Coverage (TTM)

CUEN/A

IVVDN/A

Net Debt/EBITDA (TTM)

CUE0.00x

IVVD0.00x

Beta

CUE2.84

IVVD1.32

52W Performance

CUE7.5%

IVVD-56.0%

YTD Performance

CUE173.6%

IVVD-71.2%

% from 52W High

CUE-39.2%

IVVD-76.5%

% from 52W Low

CUE456.4%

IVVD36.7%

Asset Turnover (TTM)

CUE1.11x

IVVD0.27x

FCF Yield (TTM)

CUE-44.8%

IVVD-51.6%

Earnings Yield (TTM)

CUE-146.5%

IVVD-50.5%

Dividend Yield (TTM)

CUEN/A

IVVDN/A

Rule of 40

CUE221.1

IVVD-161.6

EV/GP/RG

CUEN/A

IVVD0.06

Ticker research

View CUE research View IVVD research

Metric	CUE Cue Biopharma Inc	IVVD Invivyd Inc
Market & Valuation
Market Cap	$112M	$212M
Enterprise Value	$95M	$52M
Price	$27.66	$0.72
P/E Ratio	N/A	N/A
P/S Ratio	2.98x	3.64x
EV/Sales	2.51x	0.90x
EV/EBITDA	0.00x	0.00x
P/B Ratio	80.41x	1.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.89x	-0.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.13x
Revenue & Growth
Revenue (TTM)	$38M	$58M
Revenue Growth (YoY)	354.4%	26.3%
Forward Rev Growth	-38.2%	44.8%
Profitability
Gross Margin (TTM)	0.0%	92.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-258.4%	-191.7%
Net Margin (TTM)	-435.8%	-183.9%
FCF Margin (TTM)	-133.2%	-187.9%
Net Income (TTM)	$-164M	$-107M
FCF (TTM)	$-50M	$-110M
EPS (TTM)	-$25.88	-$0.33
ROE (TTM)	-103219.0%	-5973.0%
ROA (TTM)	-48467.0%	-4897.0%
ROIC (TTM)	-100612.0%	-5973.0%
Financial Health
Cash	$17M	$160M
Debt	$0	$0
Net Cash/Debt	$17M	$160M
Current Ratio (TTM)	1.25x	5.87x
Quick Ratio (TTM)	1.16x	5.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.84	1.32
52W Performance	7.5%	-56.0%
YTD Performance	173.6%	-71.2%
% from 52W High	-39.2%	-76.5%
% from 52W Low	456.4%	36.7%
Efficiency & Yields
Asset Turnover (TTM)	1.11x	0.27x
FCF Yield (TTM)	-44.8%	-51.6%
Earnings Yield (TTM)	-146.5%	-50.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	221.1	-161.6
EV/GP/RG	N/A	0.06
Ticker research	View CUE research	View IVVD research